Joseph Jennings - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Joseph Jennings

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Current Vascular Pharmacology|July 6, 2017

NAFLD-NASH: An Under-Recognized EpidemicJoseph Jennings, Charles Faselis, Michael D Yao

Gastroenterology & Hepatology|March 21, 2025

Uncovering the Hidden Link Between the Aberrant Intestinal Microbiome and FibromyalgiaAde Waterman, Stavros A Doumas, Michele Fischer, et al.

Journal for Immunotherapy of Cancer|December 7, 2018

Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor-induced colitis: a multi-center studyHamzah Abu-Sbeih, Faisal S Ali, Dana Alsaadi, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Current Vascular Pharmacology|July 6, 2017

NAFLD-NASH: An Under-Recognized EpidemicJoseph Jennings, Charles Faselis, Michael D Yao

Gastroenterology & Hepatology|March 21, 2025

Uncovering the Hidden Link Between the Aberrant Intestinal Microbiome and FibromyalgiaAde Waterman, Stavros A Doumas, Michele Fischer, et al.

Journal for Immunotherapy of Cancer|December 7, 2018

Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor-induced colitis: a multi-center studyHamzah Abu-Sbeih, Faisal S Ali, Dana Alsaadi, et al.

Pageof 1